We found that isoflavone genistein could increase apoptosis and enhance the anti-tumor activity of chemotherapeutic agents via the down-regulation of NF-κB signaling [93], suggesting the potential therapeutic effects of isoflavone in cancer treatment. The gene discussed is NFKB1; the disease is cancer.